115 related articles for article (PubMed ID: 16344131)
1. Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery.
Crowder KC; Hughes MS; Marsh JN; Barbieri AM; Fuhrhop RW; Lanza GM; Wickline SA
Ultrasound Med Biol; 2005 Dec; 31(12):1693-700. PubMed ID: 16344131
[TBL] [Abstract][Full Text] [Related]
2. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.
Wong HL; Bendayan R; Rauth AM; Xue HY; Babakhanian K; Wu XY
J Pharmacol Exp Ther; 2006 Jun; 317(3):1372-81. PubMed ID: 16547167
[TBL] [Abstract][Full Text] [Related]
3. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.
Winter PM; Cai K; Caruthers SD; Wickline SA; Lanza GM
Expert Rev Med Devices; 2007 Mar; 4(2):137-45. PubMed ID: 17359221
[TBL] [Abstract][Full Text] [Related]
4. A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands.
Yao YC; Zhan XY; Zhang J; Zou XH; Wang ZH; Xiong YC; Chen J; Chen GQ
Biomaterials; 2008 Dec; 29(36):4823-30. PubMed ID: 18824258
[TBL] [Abstract][Full Text] [Related]
5. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
Messerschmidt SK; Musyanovych A; Altvater M; Scheurich P; Pfizenmaier K; Landfester K; Kontermann RE
J Control Release; 2009 Jul; 137(1):69-77. PubMed ID: 19306900
[TBL] [Abstract][Full Text] [Related]
6. Engineered nanoparticles as precise drug delivery systems.
Yih TC; Al-Fandi M
J Cell Biochem; 2006 Apr; 97(6):1184-90. PubMed ID: 16440317
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle and targeted systems for cancer therapy.
Brannon-Peppas L; Blanchette JO
Adv Drug Deliv Rev; 2004 Sep; 56(11):1649-59. PubMed ID: 15350294
[TBL] [Abstract][Full Text] [Related]
8. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
[TBL] [Abstract][Full Text] [Related]
9. Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis.
Winter PM; Neubauer AM; Caruthers SD; Harris TD; Robertson JD; Williams TA; Schmieder AH; Hu G; Allen JS; Lacy EK; Zhang H; Wickline SA; Lanza GM
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2103-9. PubMed ID: 16825592
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
Mandal BB; Kundu SC
Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
[TBL] [Abstract][Full Text] [Related]
11. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
[TBL] [Abstract][Full Text] [Related]
12. Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme.
Nikanjam M; Gibbs AR; Hunt CA; Budinger TF; Forte TM
J Control Release; 2007 Dec; 124(3):163-71. PubMed ID: 17964677
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
Li SD; Huang L
Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled drug delivery systems. 1. Properties and in vitro/in vivo behavior of acyclovir self-assembled nanoparticles (SAN).
Jin Y; Tong L; Ai P; Li M; Hou X
Int J Pharm; 2006 Feb; 309(1-2):199-207. PubMed ID: 16377106
[TBL] [Abstract][Full Text] [Related]
15. Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging.
Kumar R; Roy I; Ohulchanskyy TY; Goswami LN; Bonoiu AC; Bergey EJ; Tramposch KM; Maitra A; Prasad PN
ACS Nano; 2008 Mar; 2(3):449-56. PubMed ID: 19206569
[TBL] [Abstract][Full Text] [Related]
16. Solid lipid nanoparticles for targeted brain drug delivery.
Blasi P; Giovagnoli S; Schoubben A; Ricci M; Rossi C
Adv Drug Deliv Rev; 2007 Jul; 59(6):454-77. PubMed ID: 17570559
[TBL] [Abstract][Full Text] [Related]
17. The enhancement effect of gold nanoparticles in drug delivery and as biomarkers of drug-resistant cancer cells.
Li J; Wang X; Wang C; Chen B; Dai Y; Zhang R; Song M; Lv G; Fu D
ChemMedChem; 2007 Mar; 2(3):374-8. PubMed ID: 17206735
[TBL] [Abstract][Full Text] [Related]
18. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
Wang XL; Xu R; Lu ZR
J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
[TBL] [Abstract][Full Text] [Related]
19. [Advances in the study of lipid-based cubic liquid crystalline nanoparticles as drug delivery system].
Wu HB; Huo DF; Jiang XG
Yao Xue Xue Bao; 2008 May; 43(5):450-5. PubMed ID: 18717329
[TBL] [Abstract][Full Text] [Related]
20. Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery.
Bergen JM; von Recum HA; Goodman TT; Massey AP; Pun SH
Macromol Biosci; 2006 Jul; 6(7):506-16. PubMed ID: 16921538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
